Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
MedImmune, LLC
Scientific Title
A Phase 1, Open-label Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma